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Regioselective prenylation of bromocarbazoles by
palladium(0)-catalysed cross coupling – synthesis
of O-methylsiamenol, O-methylmicromeline and
carquinostatin A†‡
Claudia Thomas, Olga Kataeva, Arndt W. Schmidt and Hans-Joachim Knölker*
We describe the regioselective prenylation of 3-bromocarbazole
by palladium(0)-catalysed cross coupling with a prenylstannane or
a prenylboronate. The procedure is applied to the synthesis of
precursors for biologically active carbazole alkaloids.
The prenyl (3,3-dimethylallyl) substituent is a characteristic
structural feature of numerous natural products. Biosyntheti-
cally, a prenyl group is introduced by reaction with prenyl
pyrophosphate, formed either by the mevalonic acid or the
methylerythritol phosphate pathway.1 Various carbazole alka-
loids with a prenyl substituent have been isolated from natural
sources,2 e.g. the antibacterial carquinostatin A (1),3 the anti-
TB active micromeline (2)4 and the anti-HIV active siamenol
(3) (Fig. 1).5
We described the total syntheses of carquinostatin A (1),6
micromeline (2),7 siamenol (3)8 and further prenylated carba-
zoles using either palladium(II)-catalysed or iron(0)-mediated
reactions for construction of the carbazole skeleton.9 Introduc-
tion of the prenyl substituent was achieved by a late-stage
cross coupling of the corresponding bromocarbazole with bis-
[µ-bromo-(η3-1,1-dimethylallyl)nickel] (4). Complex 4 is readily
prepared by reaction of prenyl bromide with tetracarbonyl-
nickel and has been applied to the prenylation of alkyl and
aryl halides.10 The dimeric pi-prenylnickel bromide complex 4
provides satisfactory results in the cross coupling reaction with
bromocarbazoles and tolerates many functional groups includ-
ing free phenolic hydroxy groups. However, the nickel complex
4 has some drawbacks: (1) highly toxic tetracarbonylnickel is
used for its preparation, (2) over-stoichiometric amounts of
complex 4 are required for the coupling reaction and (3)
complex 4 is very sensitive to oxygen. Therefore, a range of
methods has been developed for the palladium-catalysed pre-
nylation or tert-prenylation of aryl and heteroaryl ring
systems.11
Palladium-catalysed prenylations often lead to mixtures of
products resulting from either isomerisation via the inter-
mediate pi-allyl–palladium complex or allyl inversion in the trans-
metallation step.11,12 Herein, we report an eﬃcient procedure
for the palladium(0)-catalysed cross coupling of prenylmetal
species with bromocarbazoles containing an unprotected
carbazole nitrogen atom.
We selected 3-bromocarbazole (5) as a model compound in
order to develop a general procedure for the prenylation of car-
bazoles (Scheme 1). The reaction of 5 with the dimeric nickel
complex 4 aﬀorded 3-prenylcarbazole (6) in 80–85% yield. Our
first attempts to achieve a palladium(0)-catalysed Stille cross
coupling of 5 and tributylprenylstannane (8) resulted mainly
in hydrodebromination to carbazole. Screening a variety of
Fig. 1 Naturally occurring prenylated carbazole alkaloids and bis[µ-bromo-
(η3-1,1-dimethylallyl)nickel] (4).
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ligands, palladium sources and additives, we found that appli-
cation of Pd(dba)2 in the presence of tri-tert-butylphosphane
and caesium fluoride (cf. the analogous conditions reported
by Schmalz et al. for the prenylation of bromoarenes)13 gave
the best conversion and no detectable hydrodebromination
(Table 1).
Cross coupling of the prenylstannane 8 with 3-bromocarba-
zole (5) occurred with complete inversion of the allyl system
and provided 3-tert-prenylcarbazole (7). The structure of com-
pound 7 has been unambiguously confirmed by a single
crystal X-ray analysis (Fig. 2). On the other hand, coupling of
the tert-prenylstannane 914 with 5 provided the desired 3-pre-
nylcarbazole (6) in 82% yield without any trace of 7 via inver-
sion of the allyl system. In line with these observations, using
a mixture of the prenylstannane 8 and the tert-prenylstannane
9 (ratio 1 : 5.9) for the cross coupling with 5 aﬀorded a mixture
of the prenylcarbazole 6 and the tert-prenylcarbazole 7 (ratio
5 : 1). The tert-prenylstannane 9 is not stable towards 1,3-iso-
merisation.14,15 A thermal rearrangement of 9 to 8 can be fol-
lowed over 1 h by 1H NMR spectroscopy in DMF-d7 at 80 °C.
Thus, we tested the Suzuki–Miyaura coupling which has the
additional advantage that toxic tin reagents are avoided.16 The
prenylboronate 10 and the tert-prenylboronate 11 were applied
to the palladium(0)-catalysed coupling with 3-bromocarbazole
(5) (Scheme 1, Table 1).17 Cross coupling of the prenylboronate
10 with 5 aﬀorded 3-tert-prenylcarbazole (7) in 89% yield by
complete inversion of the allyl system. Analogously, cross
coupling of the tert-prenylboronate 11 with 5 provided exclu-
sively 3-prenylcarbazole (6).
Finally, we applied the palladium(0)-catalysed prenylation
to precursors for the total synthesis of biologically active
carbazole alkaloids (Scheme 2). Palladium(0)-catalysed
coupling of the bromocarbazole 126a–c,18 with the tert-prenyl-
stannane 9 or the tert-prenylboronate 11 provided the prenyl-
carbazole 13 in 78% and 85% yield, respectively. We have
shown previously that compound 13 is easily converted into
carquinostatin A (1) by removal of the acetyl group and oxi-
dation to an ortho-quinone.6a–c Coupling of 6-bromo-7-
methoxy-3-methylcarbazole (14)8 and the tert-prenylboronate 11
provided O-methylsiamenol (15) and thus demonstrated that
an ortho-substituent is tolerated. Due to the peri-interaction,
coupling reactions at position 4 or 5 respectively of the carba-
zole skeleton can be diﬃcult. Using the present procedure,
cross coupling of 5-bromo-6-methoxycarbazole-3-carbaldehyde (16)7
and the tert-prenylboronate 11 under optimised conditions
provided O-methylmicromeline (17)19 in 83% yield. Micro-
meline (2) and some derivatives of carbazole 12 were shown to
exhibit anti-TB activity.4,20
In conclusion, we have described the regioselective intro-
duction of prenyl and tert-prenyl groups at bromocarbazoles in
high yields. Both substituents are introduced by palladium(0)-
catalysed cross coupling with complete inversion of the allyl
system of the corresponding stannane or boronate reagents.
The methodology has been applied to the direct prenylation of
precursors for biologically active carbazole alkaloids and is
superior to two-step procedures involving allylation followed
by olefin cross metathesis with isobutene using Grubbs II
catalyst.21
Scheme 1 Palladium(0)-catalysed coupling of 3-bromocarbazole (5)
with the prenyl reagents 8, 10 and the tert-prenyl reagents 9, 11; (pin) =
pinacolato.
Table 1 Reagents and conditions for the prenylation of 3-bromocarbazole (5)
Reagent Reaction conditions Ratio 6 : 7a
4 5.0 equiv. Ni(CO)4, 2.0 equiv. prenyl bromide, PhH, reflux, 0.5 h; then DMF, 50 °C, 2 d 1 : 0
8 10 mol% Pd(dba)2, 24 mol% tBu3P, 1.2 equiv. 8, 1.6 equiv. CsF, DMF, rt, 24 h 0 : 1
9 10 mol% Pd(dba)2, 24 mol% tBu3P, 1.2 equiv. 9, 1.6 equiv. CsF, DMF, rt, 24 h 1 : 0
8 + 9 (1 : 5.9)a 10 mol% Pd(dba)2, 24 mol% tBu3P, 1.2 equiv. 8 + 9, 1.6 equiv. CsF, DMF, rt, 24 h 5.0 : 1
10 16 mol% Pd(dba)2, 31 mol% tBu3P, 1.5 equiv. 10, 4.0 equiv. CsF, DMF, rt, 24 h 0 : 1
11 16 mol% Pd(dba)2, 31 mol% tBu3P, 1.5 equiv. 11, 4.0 equiv. CsF, DMF, rt, 24 h 1 : 0
a Ratio as determined by NMR integration; yields: 80–90% of 6 and 7.
Fig. 2 Molecular structure of 3-tert-prenylcarbazole (7) in the crystal.
ORTEP plot showing thermal ellipsoids at the 50% probability level.§
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